Private Trust Company’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Private Trust Company’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-78	Closed	-$2K	–	1370
2014 Q3	$2K	Hold	78	–	–	﹤0.01%	1644
2014 Q2	$2K	Hold	78	–	–	﹤0.01%	1642
2014 Q1	$2K	Sell	78 -14	-15%	-$374	﹤0.01%	1528
2013 Q4	$2K	Hold	92	–	–	﹤0.01%	1536
2013 Q3	$2K	Hold	92	–	–	﹤0.01%	1487
2013 Q2	$2K	Buy	+92	New	+$1.83K	﹤0.01%	1418

Other funds holding PTLA

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Private Trust Company's PTLA Position: Q4 2014 in Review

Private Trust Company sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q4 2014, closing a stake of 78 shares — an estimated $2K sold.

Private Trust Company first reported a position in PTLA in Q2 2013 and held it in 6 quarters. The position peaked at $2K in Q3 2014. 133 funds tracked by Wall St. Rank hold PTLA as of Q4 2014.

Private Trust Company reported no remaining Portola Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
Private Trust Company sold 78 Portola Pharmaceuticals, Inc. shares in Q4 2014, an estimated $2K.
Private Trust Company first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 6 quarters.
Private Trust Company's Portola Pharmaceuticals, Inc. position peaked at $2K in Q3 2014.
133 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2014.

Based on Private Trust Company's 13F filing for Q4 2014, filed 28 Jan 2015.